Bone Density and Aging: What You Need to Know

Learn about osteoporosis prevention and how DEXA scans can help monitor your bone health as you age.

The Silent Process of Bone Loss

Bone loss is one of the most insidious health conditions precisely because it produces no symptoms until significant damage has occurred. Most people first learn their bone density is compromised after a fracture — a fall that breaks a hip, a minor injury that fractures a wrist, or back pain that turns out to be a vertebral compression fracture.

By that point, osteoporosis is typically well established. The opportunity for prevention has passed. This is why proactive bone density monitoring through DEXA scanning matters so much: it catches bone loss at a stage when intervention can be genuinely effective.

How Bone Density Changes With Age

Bone mass follows a predictable arc over the human lifespan. It increases rapidly through childhood and adolescence, peaks in the mid-to-late 20s, remains relatively stable through the 30s and early 40s, and then begins a gradual decline.

For women, this decline accelerates dramatically at menopause. The loss of estrogen triggers osteoclast activity — the cells responsible for breaking down bone tissue — while slowing osteoblast activity — the cells that build new bone. In the first 5 to 7 years after menopause, women can lose 2 to 4% of bone mass per year. Men experience a slower, more linear decline throughout aging, but are not immune to significant bone loss.

Understanding T-Scores and Z-Scores

Your DEXA bone density report will include two comparison scores. The T-score compares your bone mineral density to the average peak bone mass of a healthy 30-year-old of the same sex. A T-score of −1.0 or above is normal. Between −1.0 and −2.5 indicates osteopenia (low bone mass). A T-score below −2.5 meets the clinical definition of osteoporosis.

The Z-score compares your bone density to others of your age, sex, and sometimes body size. A Z-score below −2.0 is considered below the expected range for your age group and may prompt your physician to investigate secondary causes of bone loss — conditions such as hyperparathyroidism, vitamin D deficiency, celiac disease, or long-term corticosteroid use.

Who Should Get Bone Density Testing?

Current clinical guidelines recommend DEXA bone density screening for all women aged 65 and older, and for younger postmenopausal women with risk factors including a family history of osteoporosis, smoking, low body weight, or prolonged corticosteroid use. Men over 70, or younger men with equivalent risk factors, should also consider baseline testing.

However, these are minimum recommendations for clinical screening — not optimal monitoring. Athletes, particularly those in weight-class or aesthetic sports with a history of caloric restriction, young women with menstrual irregularities, and anyone with a personal history of fractures may benefit from earlier and more frequent monitoring.

Proven Strategies to Protect Bone Density

The most effective lifestyle intervention for bone health is resistance exercise — specifically, high-impact and weight-bearing activities that stress the skeleton and stimulate osteoblast activity. Walking, running, tennis, and weightlifting all confer significant bone-protective benefits. Swimming and cycling, while excellent for cardiovascular health, are non-weight-bearing and provide minimal bone stimulus.

Adequate calcium and vitamin D intake are foundational. Most adults require 1,000–1,200 mg of calcium daily and 1,500–2,000 IU of vitamin D3 per day, though individual needs vary. Avoiding smoking, limiting alcohol to moderate consumption, and managing corticosteroid use with your physician are additional modifiable risk factors.

When Medication Becomes Appropriate

For individuals with established osteoporosis or osteopenia combined with high fracture risk, lifestyle modifications alone are often insufficient. Several classes of medication have been shown in randomized controlled trials to significantly reduce fracture risk: bisphosphonates (alendronate, risedronate), denosumab, romosozumab, and anabolic agents like teriparatide.

The decision to begin pharmacological therapy is made jointly between you and your physician, taking into account your T-scores, FRAX fracture risk assessment, medical history, and preferences. Serial DEXA scans are the primary tool for monitoring whether treatment is working — typically performed every 1 to 2 years on therapy.

Monitoring Your Bone Health Over Time

A single DEXA scan gives you a snapshot; serial scans give you the trajectory. The difference between a person losing bone at 1% per year versus 0.1% per year is enormously consequential over a decade, but invisible without regular measurement.

If your T-scores are normal and you have no significant risk factors, the standard recommendation is to retest every 2 years starting at age 65 for women. If you have risk factors, osteopenia, or are on treatment, annual monitoring provides the feedback loop needed to adjust interventions promptly. Don't wait for a fracture to find out where your bone health stands.

Medical Disclaimer: The information provided on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. DEXA scan results should be interpreted by a qualified healthcare professional.